SOLVANIX

Solvanix is a biotechnology company that improves stability and reducing the aggregation of fully human antibodies. Traditional monoclonal and fragment antibodies can have limited stability and a tendency to aggregate, which greatly impacts manufacturability, formulation and product quality. Solvanix’ proprietary StAbilize™ technology works by boosting stability and reducing aggregation of monoclonal antibodies, antibody fragments and bi-specifics. The Company is working with its biotech and pharma partners to improve their therapeutic antibodies and is providing licenses to the StAbilize™ technology.

#SimilarOrganizations #People #Financial #Website #More

SOLVANIX

Industry:

Biotechnology Health Care Pharmaceutical

Founded:

2014-01-01

Address:

Darlinghurst, New South Wales, Australia

Country:

Australia

Website Url:

http://www.solvanix.com

Total Employee:

51+

Status:

Active

Contact:

(206)938-5850

Email Addresses:

[email protected]

Total Funding:

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF Apache Microsoft Exchange Online Office 365 Mail Google Maps Microsoft Azure DNS Network Solutions DNS PyroCMS